1. Koenig, Sara N, Cavus, Omer, Williams, Jordan, Mohler, Peter J, Bradley, Elisa A. 2021. New mechanistic insights to PLOD1-mediated human vascular disease. In Translational research : the journal of laboratory and clinical medicine, 239, 1-17. doi:10.1016/j.trsl.2021.08.002. https://pubmed.ncbi.nlm.nih.gov/34400365/
2. Yan, Xiaodan, Shu, Jianbo, Nie, Yanyan, Cui, Xiaoyu, Liu, Yang. 2022. Case Report: Identification and Functional Analysis of a Homozygous Synonymous Variant in the PLOD1 Gene in a Chinese Neonatal With the Ehlers-Danlos Syndrome. In Frontiers in pediatrics, 10, 813758. doi:10.3389/fped.2022.813758. https://pubmed.ncbi.nlm.nih.gov/35252061/
3. Tian, Lei, Zhou, Huandi, Wang, Guohui, Li, Yuehong, Xue, Xiaoying. 2021. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases. In PeerJ, 9, e11422. doi:10.7717/peerj.11422. https://pubmed.ncbi.nlm.nih.gov/34040895/
4. Wang, Zhenlin, Shi, Yuping, Ying, Chenting, Jiang, Yang, Hu, Jiangfeng. 2021. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling. In Oncogene, 40, 1458-1475. doi:10.1038/s41388-020-01635-y. https://pubmed.ncbi.nlm.nih.gov/33420370/
5. Chi, Ming, Liu, Jiao, Mei, Chenxue, Meng, Xin, Wang, Biao. 2022. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. In Journal of experimental & clinical cancer research : CR, 41, 175. doi:10.1186/s13046-022-02377-3. https://pubmed.ncbi.nlm.nih.gov/35581606/
6. Wu, Xiaolin, Xiang, Hongfei, Cong, Wenbin, Shen, Yanqing, Chen, Bohua. 2020. PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma. In Biochemical and biophysical research communications, 527, 29-36. doi:10.1016/j.bbrc.2020.04.052. https://pubmed.ncbi.nlm.nih.gov/32446383/
7. Jiang, Haoli, Guo, Wei, Yuan, Shanyou, Song, Lixia. 2020. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma. In BioMed research international, 2020, 3418398. doi:10.1155/2020/3418398. https://pubmed.ncbi.nlm.nih.gov/33134376/
8. Ni, Xiaolin, Jin, Chenxi, Jiang, Yan, Xing, Xiaoping, Xia, Weibo. 2020. The first case report of Kyphoscoliotic Ehlers-Danlos syndrome of chinese origin with a novel PLOD1 gene mutation. In BMC medical genetics, 21, 214. doi:10.1186/s12881-020-01154-3. https://pubmed.ncbi.nlm.nih.gov/33129265/
9. Wang, Hao, Luo, Weijian, Dai, Limeng. 2020. Expression and Prognostic Role of PLOD1 in Malignant Glioma. In OncoTargets and therapy, 13, 13285-13297. doi:10.2147/OTT.S265866. https://pubmed.ncbi.nlm.nih.gov/33402837/